We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Patient-Derived Human Primary Cancer Cells

Product News   Feb 02, 2021

 
Patient-Derived Human Primary Cancer Cells

Immunocytochemical analysis of human primary breast cancer cells in vitro, EGFR expression (red) and TP53 (green), DAPI blue. Credit: AMSBIO

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Adaptate Biotherapeutics Raises $18 million in Series A2 Funding

Product News

Adaptate Biotherapeutics has announced that its existing investors, Abingworth and Takeda Pharmaceutical Company Limited have together made a further equity investment of $18 million.

READ MORE

Eppendorf Introduces Multipurpose Centrifuge 5910 Ri To Accelerate Results

Product News

Eppendorf has introduced a new centrifuge designed to increase efficiency in the laboratory, Centrifuge 5910 Ri.

READ MORE

Lonza Celebrates 20th Anniversary of Nucleofector Cell Transfection Platform

Product News

2021 marks the 20th anniversary of Lonza’s Nucleofector™ Technology, the industry’s leading non-viral cell transfection method, which has been cited more than 10,000 times, including in research by two Nobel Laureates.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE